参考文献/References:
[1] Owan TE,Hodge DO,Herges RM,et al.Trends in prevalence and outcome of heart failure with preserved ejection fraction[J].N Engl J Med,2006,355(3):251-259.
[2] Kitzman DW.Heart failure with normal systolic function[J].Clin Geriatr Med,2000,16(3):489-512.
[3] Trenor B, Cardona K, Gomez JF, et al.Simulation and mechanistic investigation of the arrhythmogenic role of the late sodium current in human[J].PLoS One, 2012,7(3):e32659.
[4] Denac H,Mevissen M,Scholtysik G.Structure,function and pharmacology of voltage-gated sodium channels[J].Naunyn Schmiedebergs Arch Pharmacol,2000,62(6):453-479.
[5] Schwarz N, Hahn A, Bast T,et al.Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia[J].J Neurol,2015,1(1):1-2.
[6] Todt H, Dudley SC Jr, Kyle JW,et al.Ultra-slow inactivation in mu1 Na+ channels is produced by a structural rearrangement of the outer vestibule[J].Biophys J,1999,76(3):1335-1345.
[7] Maltsev VA, Kyle JW, Mishra S, et al.Molecular identity of the late sodium current in adult dog cardiomyocytes identified by Nav1.5 antisense inhibition[J].Am J Physiol Heart Circ Physiol,2008,295(2):H667-676.
[8] Yang T,Atack TC,Stroud DM,et al.Blocking SCN10A channels in heart reduces late sodium current and is antiarrhythmic[J].Circ Res,2012,111(3):322-332.
[9] Kornyeyev D,El-Bizri N,Hirakawa R,et al.Contribution of the late sodium current to intracellular sodium and calcium overload in rabbit ventricular myocytes treated by anemone toxin[J].Am J Physiol Heart Circ Physiol,2015,37(62):27-32.
[10] London B.Whither art thou,SCN10A,and what art thou doing?[J].Circ Res,2012, 111(3):268-270.
[11] Noble D,Noble PJ.Late sodium current in the pathophysiology of cardiovascular disease:consequences of sodium-calcium overload[J].Heart,2006,92(suppl 4):iv1-iv5.
[12] Holm H,Gudbjartsson DF,Arnar DO,et al.Several common variants modulate heart rate, PR interval and QRS duration[J].Nat Genet,2010,42(2):117-122.
[13] Maier LS.New treatment options for late Na current, arrhythmias,and diastolic dysfunction[J].Curr Heart Fail Rep,2012,9(3):183-191.
[14] Ju YK, Saint DA, Gage PW.Hypoxia increases persistent sodium current in rat ventricular myocytes[J].J Physiol,1996,497(2):337-347.
[15] Chen Y,Yu FH,Surmeier DJ,et al.Neuromodulation of Na+ channel slow inactivation via cAMP-dependent protein kinase and protein kinase C[J].Neuron,2006,49(3):409-420.
[16] Moreno JD, Clancy CE.Pathophysiology of the cardiac late Na current and its potential as a drug target[J].J Mol Cell Cardiol,2012,52(3):608-619.
[17] Mishra S, Undrovinas NA, Maltsev VA, et al.Post-transcriptional silencing of SCN1B and SCN2B genes modulates late sodium current in cardiac myocytes from normal dogs and dogs with chronic heart failure[J].Am J Physiol Heart Circ Physiol,2011,301(4):H1596-1605.
[18] Bai Y,Morgan EE,Giovannucci DR,et al.Different roles of the cardiac Na+/Ca2+-exchanger in ouabain-induced inotropy, cell signaling, and hypertrophy[J].Am J Physiol Heart Circ Physiol,2013,304(3):H427-435.
[19] Wu Y, Wang L, Ma J,et al.Protein kinase C and Ca2+-calmodulin-dependent protein kinase Ⅱ mediate the enlarged reverse INCX induced by ouabain-increased late sodium current in rabbit ventricular myocytes[J].Exp Physiol,2015,100(4):399-409.
[20] Wagner S, Dybkova N, Rasenack EC,et al.Ca2+/calmodulin-dependent protein kinase Ⅱ regulates cardiac Na+ channels[J].J Clin Invest,2006,116(12):3127-3138.
[21] Zhang XQ, Yamada S,Barry WH.Ranolazine inhibits an oxidative stress-induced increase in myocyte sodiumand calcium loading during simulated-demand ischemia[J].J Cardiovasc Pharmacol,2008,51(5):443-449.
[22] Sossalla S, Maurer U, Schotola H, et al.Diastolic dysfunction and arrhythmias caused by overexpression of CaMKⅡδC can be reversed by inhibition of late Na+ current[J].Basic Res Cardiol, 2011,106(2):263-272.
[23] Sossalla S,Fluschnik N,Schotola H,et al.Inhibition of elevated Ca2+/calmodulin-dependent protein kinase Ⅱ improves contractility in human failing myocardium[J].Circ Res,2010,107(9):1150-1161.
[24] Anderson ME,Brown JH,Bers DM.CaMKⅡ in myocardial hypertrophy and heart failure[J].J Mol Cell Cardiol,2011,151(4):468-473.
[25] Pourrier M, Williams S, McAfee D,et al.CrossTalk proposal:the late sodium current is an important player in the development of diastolic heart failure[J].J Physiol,2014,592(3):411-414.
[26] Belardinelli L,Liu G,Smith-Maxwell C,et al.A novel,potent,and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias[J].J Pharmacol Exp Ther,2013,344(1):23-32.
[27] Sossalla S, Kallmeyer B, Wagner S, et al.Altered Nat-currents in atrial fibrillation: effects of ranolazine on arrhythmias and contractility in human atrial myocardium[J].J Am Coll Cardiol,2010,55(21):2330-2342.
[28] Sicouri S, Glass A, Belardinelli L,et al.Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations[J].Europace,2008,5(7):1019-1026.
[29] Adakkak M, Camara AK, Heisner JS,et al.Ranolazine reduces Ca2+ overload and oxidative stress and improves mitochondrial intergrity to protect against ischemia reperfusion injury in isolated hearts[J].Pharmacol Res,2011,64(4):381-392.
[30] Figueredo VM, Pressman GS, Romero-Corral A, et al.Improvement in left ventricular systolic and diastolic performance during ranolazine treatment in patients with stable angina[J].Cardiovasc Pharmacol Ther,2011,16(2):168-172.
[31] Maier LS, Layug B, Karwatowska-Prokopczuk E,et al.RAnoLazIne for the treatment of diastolic heart failure in patients with preserved ejection fraction: the RALI-DHF proof-of-concept study[J].JACC Heart Fail,2013,1(2):115-122.
[32] Jacobshagen C,Belardinelli L,Hasenfuss G,et al.Ranolazine for the treatment of heart failure with preserved ejection fraction:background,aims,and design of the RALI-DHF study[J].Clin Cardiol,2011,34(7):426-432.